{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:40:32Z","timestamp":1786117232501,"version":"build-2736575974"},"reference-count":131,"publisher":"Elsevier","isbn-type":[{"value":"9780443470387","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008211","name":"Drexel University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016678","name":"Margaret Q. Landenberger Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016678","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apha.2026.05.005","type":"book-chapter","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:49:17Z","timestamp":1779709757000},"page":"141-177","source":"Crossref","is-referenced-by-count":0,"title":["Manufacturing as biology: How T-cell processing shapes therapeutic outcomes"],"prefix":"10.1016","author":[{"given":"Nikolai","family":"Przybylski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.omton.2025.200980","article-title":"Cost-effective strategies for CAR-T cell therapy manufacturing","volume":"33","author":"Abdo","year":"2025","journal-title":"Molecular Therapy Oncology"},{"issue":"7774","key":"10.1016\/bs.apha.2026.05.005_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.retram.2024.103489","article-title":"Accelerating CAR T cell manufacturing with an automated next-day process","volume":"73","author":"Ahmadi","year":"2025","journal-title":"Current Research in Translational Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2026.05.005_bib4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","article-title":"IL15 Enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype","volume":"7","author":"Alizadeh","year":"2019","journal-title":"Cancer Immunology Research"},{"issue":"12","key":"10.1016\/bs.apha.2026.05.005_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150807","article-title":"CAR T cell manufacturing from naive\/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome","volume":"132","author":"Arcangeli","year":"2022","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib6","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230903","article-title":"CAR-T cell manufacturing: Major process parameters and next-generation strategies","volume":"221","author":"Ayala Ceja","year":"2024","journal-title":"The Journal of Experimental Medicine"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.190.10.1383","article-title":"CD2 sets quantitative thresholds in T cell activation","volume":"190","author":"Bachmann","year":"1999","journal-title":"The Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2026.05.005_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1074-7613(00)80376-3","article-title":"Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation","volume":"7","author":"Bachmann","year":"1997","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annual Review of Immunology"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib10","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1078-0432.CCR-22-1922","article-title":"Tumor-infiltrating lymphocyte therapy in melanoma: Facts to the future","volume":"29","author":"Betof Warner","year":"2023","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"issue":"3","key":"10.1016\/bs.apha.2026.05.005_bib11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.168.3.1145","article-title":"Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor","volume":"168","author":"Bierer","year":"1988","journal-title":"The Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2026.05.005_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002907","article-title":"CAR T cells for treating autoimmune diseases","volume":"9","author":"Blache","year":"2023","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/bs.apha.2026.05.005_bib13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/ten.tec.2016.0184","article-title":"Ammonium-chloride-potassium lysing buffer treatment of fully differentiated cells increases cell purity and resulting neotissue functional properties","volume":"22","author":"Brown","year":"2016","journal-title":"Tissue Engineering. Part C, Methods"},{"issue":"22","key":"10.1016\/bs.apha.2026.05.005_bib14","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T cells and T-cell therapies for cancer: A translational science review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA: the Journal of the American Medical Association"},{"issue":"12","key":"10.1016\/bs.apha.2026.05.005_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124197","article-title":"Recombinant adeno-associated viral vectors (rAAV)-Vector elements in ocular gene therapy clinical trials and transgene expression and bioactivity assays","volume":"21","author":"Buck","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2026.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3616120","article-title":"Human platelet lysate media supplement supports lentiviral transduction and expansion of human T lymphocytes while maintaining memory phenotype","volume":"2019","author":"Canestrari","year":"2019","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/bs.apha.2026.05.005_bib17","article-title":"CAR-T cell therapy clinical trials: Global progress, challenges, and future directions from ClinicalTrials.gov insights","volume":"16","author":"Cao","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"Journal of Immunology"},{"issue":"5, ement","key":"10.1016\/bs.apha.2026.05.005_bib19","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/j.jcyt.2020.03.283","article-title":"Vector copy number quality control testing for CAR T-cells: critical validation parameters","volume":"22","author":"Chen","year":"2020","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/bs.apha.2026.05.005_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2012-05-431718","article-title":"IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors","volume":"121","author":"Cieri","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/bs.apha.2026.05.005_bib21","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1158\/2326-6066.CIR-18-0691","article-title":"TGF\u03b2 programs central memory differentiation in ex vivo-stimulated human T cells","volume":"7","author":"Dahmani","year":"2019","journal-title":"Cancer Immunology Research"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101250","article-title":"CAR-T cell manufacturing landscape-Lessons from the past decade and considerations for early clinical development","volume":"32","author":"Dias","year":"2024","journal-title":"Molecular Therapy Methods & Clinical Development"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12943-022-01559-z","article-title":"Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing","volume":"21","author":"Dimitri","year":"2022","journal-title":"Molecular Cancer"},{"issue":"4","key":"10.1016\/bs.apha.2026.05.005_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.apha.2026.05.005_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.675179","article-title":"IL-21 optimizes the CAR-T cell preparation through improving lentivirus mediated transfection efficiency of T cells and enhancing CAR-T cell cytotoxic activities","volume":"8","author":"Du","year":"2021","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"4","key":"10.1016\/bs.apha.2026.05.005_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","article-title":"Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients","volume":"26","author":"Dudley","year":"2003","journal-title":"Journal of Immunotherapy (Hagerstown, Md.: 1997)"},{"issue":"9","key":"10.1016\/bs.apha.2026.05.005_bib27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/eji.201948455","article-title":"Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8(+) T cells","volume":"50","author":"Dwyer","year":"2020","journal-title":"European Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/intimm\/5.1.97","article-title":"N-acetylcysteine enhances T cell functions and T cell growth in culture","volume":"5","author":"Eylar","year":"1993","journal-title":"International Immunology"},{"issue":"7643","key":"10.1016\/bs.apha.2026.05.005_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ijc.33212","article-title":"Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients","volume":"148","author":"Fan","year":"2021","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4049\/jimmunol.172.1.104","article-title":"Activation of resting human primary T cells with chimeric receptors: Costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain","volume":"172","author":"Finney","year":"2004","journal-title":"Journal of Immunology"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib32","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V97.10.3152","article-title":"Red blood cells inhibit activation-induced cell death and oxidative stress in human peripheral blood T lymphocytes","volume":"97","author":"Fonseca","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood.2019004500","article-title":"Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity","volume":"136","author":"Fultang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/bs.apha.2026.05.005_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev-cellbio-111315-125324","article-title":"TCR signal strength and T cell development","volume":"32","author":"Gascoigne","year":"2016","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"10.1016\/bs.apha.2026.05.005_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2022.850565","article-title":"Enabling allogeneic T cell-based therapies: Scalable stirred-tank bioreactor mediated manufacturing","volume":"4","author":"Gatla","year":"2022","journal-title":"Frontiers in Medical Technology"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm.4241","article-title":"T memory stem cells in health and disease","volume":"23","author":"Gattinoni","year":"2017","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2026.05.005_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41551-021-00842-6","article-title":"Rapid manufacturing of non-activated potent CAR T cells","volume":"6","author":"Ghassemi","year":"2022","journal-title":"Nature Biomedical Engineering"},{"issue":"9","key":"10.1016\/bs.apha.2026.05.005_bib39","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2326-6066.CIR-17-0405","article-title":"Reducing ex vivo culture improves the antileukemic activity of chimeric antigen receptor (CAR) T cells","volume":"6","author":"Ghassemi","year":"2018","journal-title":"Cancer Immunology Research"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib40","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8(+) T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/trf.14429","article-title":"Optimal storage conditions for apheresis research (OSCAR): A biomedical excellence for safer transfusion (BEST) collaborative study","volume":"58","author":"Gniadek","year":"2018","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/bs.apha.2026.05.005_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8030036","article-title":"Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy","volume":"8","author":"Golubovskaya","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.apha.2026.05.005_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"6","key":"10.1016\/bs.apha.2026.05.005_bib44","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","article-title":"Metabolic reprogramming of terminally exhausted CD8(+) T cells by IL-10 enhances anti-tumor immunity","volume":"22","author":"Guo","year":"2021","journal-title":"Nature Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2026.05.005_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2026.05.005_bib46","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri.2017.146","article-title":"Epigenetic control of CD8(+) T cell differentiation","volume":"18","author":"Henning","year":"2018","journal-title":"Nature Reviews. Immunology"},{"issue":"11","key":"10.1016\/bs.apha.2026.05.005_bib47","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1182\/blood-2007-09-113050","article-title":"IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy","volume":"111","author":"Hinrichs","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41565-020-00813-z","article-title":"DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation","volume":"16","author":"Huang","year":"2021","journal-title":"Nature Nanotechnology"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2024.01.011","article-title":"Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks","volume":"57","author":"Jaeger-Ruckstuhl","year":"2024","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib50","doi-asserted-by":"crossref","first-page":"L5","DOI":"10.1016\/j.bpj.2011.12.011","article-title":"Mechanosensing in T lymphocyte activation","volume":"102","author":"Judokusumo","year":"2012","journal-title":"Biophysical Journal"},{"issue":"6","key":"10.1016\/bs.apha.2026.05.005_bib51","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jcyt.2017.03.067","article-title":"Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion","volume":"19","author":"Kaartinen","year":"2017","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89580","article-title":"Transient stimulation expands superior antitumor T cells for adoptive therapy","volume":"2","author":"Kagoya","year":"2017","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/bs.apha.2026.05.005_bib53","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI86437","article-title":"BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models","volume":"126","author":"Kagoya","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"issue":"68","key":"10.1016\/bs.apha.2026.05.005_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl6322","article-title":"Intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling and promotes fate decisions, stemness, and protection","volume":"7","author":"Kahan","year":"2022","journal-title":"Science Immunology"},{"issue":"5","key":"10.1016\/bs.apha.2026.05.005_bib55","first-page":"405","article-title":"Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies","volume":"27","author":"Kalamasz","year":"2004","journal-title":"Journal of Immunotherapy (Hagerstown, Md.: 1997)"},{"issue":"12","key":"10.1016\/bs.apha.2026.05.005_bib56","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/ars.2011.4073","article-title":"Redox regulation of T-cell function: From molecular mechanisms to significance in human health and disease","volume":"18","author":"Kesarwani","year":"2013","journal-title":"Antioxidants & Redox Signaling"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib57","article-title":"Optimized conditions for gene transduction into primary immune cells using viral vectors","volume":"13","author":"Kim","year":"2023","journal-title":"Scientific Reports"},{"issue":"23","key":"10.1016\/bs.apha.2026.05.005_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95103","article-title":"Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy","volume":"2","author":"Klebanoff","year":"2017","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101474","article-title":"Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing","volume":"33","author":"Kosaka","year":"2025","journal-title":"Molecular Therapy Methods & Clinical Development"},{"issue":"11","key":"10.1016\/bs.apha.2026.05.005_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007803","article-title":"CD8(+) chimeric antigen receptor T cells manufactured in absence of CD4(+) cells exhibit hypofunctional phenotype","volume":"11","author":"Lee","year":"2023","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib61","article-title":"Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation","volume":"14","author":"Li","year":"2024","journal-title":"Scientific Reports"},{"issue":"15","key":"10.1016\/bs.apha.2026.05.005_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157400","article-title":"Mitochondrial metabolism in T-cell exhaustion","volume":"26","author":"Li","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/bs.apha.2026.05.005_bib64","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/CM9.0000000000003046","article-title":"Targeting metabolism to improve CAR-T cells therapeutic efficacy","volume":"137","author":"Liu","year":"2024","journal-title":"Chinese Medical Journal\u00a0(England)"},{"issue":"12","key":"10.1016\/bs.apha.2026.05.005_bib65","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41551-024-01272-w","article-title":"Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapies","volume":"8","author":"Liu","year":"2024","journal-title":"Nature Biomedical Engineering"},{"issue":"11","key":"10.1016\/bs.apha.2026.05.005_bib66","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1182\/bloodadvances.2024013656","article-title":"Impact of vein-to-vein time in patients with R\/R LBCL treated with axicabtagene ciloleucel","volume":"9","author":"Locke","year":"2025","journal-title":"Blood Advances"},{"issue":"5","key":"10.1016\/bs.apha.2026.05.005_bib67","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/trf.12472","article-title":"T-cell suppression by red blood cells is dependent on intact cells and is a consequence of blood bank processing","volume":"54","author":"Long","year":"2014","journal-title":"Transfusion"},{"issue":"7786","key":"10.1016\/bs.apha.2026.05.005_bib68","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","article-title":"c-Jun overexpression in CAR T cells induces exhaustion resistance","volume":"576","author":"Lynn","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","article-title":"Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta \/CD28 receptor","volume":"20","author":"Maher","year":"2002","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.apha.2026.05.005_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120058","article-title":"T-cell activation is modulated by the 3D mechanical microenvironment","volume":"252","author":"Majedi","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/bs.apha.2026.05.005_bib71","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53725","article-title":"Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation","volume":"9","author":"Marchingo","year":"2020","journal-title":"Elife"},{"issue":"16","key":"10.1016\/bs.apha.2026.05.005_bib72","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.apha.2026.05.005_bib73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.omtm.2017.11.001","article-title":"Improved expansion and in vivo function of patient T cells by a serum-free medium","volume":"8","author":"Medvec","year":"2018","journal-title":"Molecular Therapy Methods & Clinical Development"},{"issue":"6","key":"10.1016\/bs.apha.2026.05.005_bib74","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.celrep.2018.01.040","article-title":"Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions","volume":"22","author":"Menk","year":"2018","journal-title":"Cell Reports"},{"issue":"21-22","key":"10.1016\/bs.apha.2026.05.005_bib75","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/hum.2022.090","article-title":"Regulatory consideration for the nonclinical safety assessment of gene therapies","volume":"33","author":"Moffit","year":"2022","journal-title":"Human Gene Therapy"},{"issue":"5259","key":"10.1016\/bs.apha.2026.05.005_bib76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science (New York, N. Y.)"},{"issue":"6","key":"10.1016\/bs.apha.2026.05.005_bib77","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s10238-022-00928-8","article-title":"Effects of polybrene and retronectin as transduction enhancers on the development and phenotypic characteristics of VHH-based CD19-redirected CAR T cells: a comparative investigation","volume":"23","author":"Nasiri","year":"2023","journal-title":"Clinical and Experimental Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2026.05.005_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126765","article-title":"4-1BB signaling enhances primary and secondary population expansion of CD8+ T cells by maximizing autocrine IL-2\/IL-2 receptor signaling","volume":"10","author":"Oh","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s41669-025-00614-x","article-title":"Cost-effectiveness of chimeric antigen receptor (CAR) T-cell therapy for blood cancers: An updated systematic review","volume":"10","author":"Patel","year":"2026","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/bs.apha.2026.05.005_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1561174","article-title":"New player in CAR-T manufacture field: Comparison of umbilical cord to peripheral blood strategies","volume":"16","author":"Rassek","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.seminhematol.2020.07.005","article-title":"Improving CAR T cell therapy by optimizing critical quality attributes","volume":"57","author":"Reddy","year":"2020","journal-title":"Seminars in Hematology"},{"issue":"23","key":"10.1016\/bs.apha.2026.05.005_bib82","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2406526","article-title":"Obecabtagene autoleucel in adults with B-cell acute lymphoblastic leukemia","volume":"391","author":"Roddie","year":"2024","journal-title":"The New England Journal of Medicine"},{"issue":"21","key":"10.1016\/bs.apha.2026.05.005_bib83","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood.2021012392","article-title":"Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia","volume":"138","author":"Rossoff","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/bs.apha.2026.05.005_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005678","article-title":"Dose-response correlation for CAR-T cells: A systematic review of clinical studies","volume":"10","author":"Rotte","year":"2022","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib85","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41591-018-0201-9","article-title":"Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell","volume":"24","author":"Ruella","year":"2018","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2026.05.005_bib86","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/14653240903219114","article-title":"Impact of culture medium on the expansion of T cells for immunotherapy","volume":"11","author":"Sato","year":"2009","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nature Immunology"},{"issue":"20","key":"10.1016\/bs.apha.2026.05.005_bib88","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1158\/0008-5472.CAN-16-0587","article-title":"Efficacy of adoptive T-cell therapy is improved by treatment with the antioxidant N-acetyl cysteine, which limits activation-induced T-cell death","volume":"76","author":"Scheffel","year":"2016","journal-title":"Cancer Research"},{"issue":"10416","key":"10.1016\/bs.apha.2026.05.005_bib89","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","article-title":"CAR T-cell therapy in autoimmune diseases","volume":"402","author":"Schett","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101954","article-title":"Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures","volume":"4","author":"Selli","year":"2023","journal-title":"STAR Protocols"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib91","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-020-1081-3","article-title":"Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: A phase 1 dose escalation and expansion trial","volume":"26","author":"Shah","year":"2020","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2026.05.005_bib92","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/bloodadvances.2024015157","article-title":"Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies","volume":"9","author":"Shahid","year":"2025","journal-title":"Blood Advances"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001608","article-title":"Off-the-shelf\u2019 allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies","volume":"9","author":"Sinha","year":"2021","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"3","key":"10.1016\/bs.apha.2026.05.005_bib94","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13534-021-00199-4","article-title":"Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicine","volume":"11","author":"Sioson","year":"2021","journal-title":"Biomedical Engineering Letters"},{"issue":"25","key":"10.1016\/bs.apha.2026.05.005_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aas9103","article-title":"TCR signal strength controls the differentiation of CD4(+) effector and memory T cells","volume":"3","author":"Snook","year":"2018","journal-title":"Science Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib96","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U. K"},{"issue":"3","key":"10.1016\/bs.apha.2026.05.005_bib97","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.it.2023.01.002","article-title":"Metabolism and epigenetics at the heart of T cell function","volume":"44","author":"Soriano-Baguet","year":"2023","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.apha.2026.05.005_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1593895","article-title":"Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors","volume":"13","author":"Springuel","year":"2025","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"10.1016\/bs.apha.2026.05.005_bib99","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cryobiol.2020.07.009","article-title":"The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patients","volume":"96","author":"Su","year":"2020","journal-title":"Cryobiology"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib100","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1172\/JCI69589","article-title":"Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function","volume":"123","author":"Sukumar","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib101","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biomaterials.2013.09.050","article-title":"Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells","volume":"35","author":"Sunshine","year":"2014","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/bs.apha.2026.05.005_bib103","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002555","article-title":"Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies","volume":"9","author":"Tantalo","year":"2021","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41408-024-01193-6","article-title":"Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies","volume":"14","author":"Tao","year":"2024","journal-title":"Blood Cancer Journal"},{"key":"10.1016\/bs.apha.2026.05.005_bib105","series-title":"Miltenyi microbeads and dynabeads magnetic beads comparison","year":"2026"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s40425-019-0804-9","article-title":"Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity","volume":"7","author":"Torres Chavez","year":"2019","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"6","key":"10.1016\/bs.apha.2026.05.005_bib107","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/immunohorizons.2400008","article-title":"T cell activators exhibit distinct downstream effects on chimeric antigen receptor T cell phenotype and function","volume":"8","author":"Underwood","year":"2024","journal-title":"Immunohorizons"},{"key":"10.1016\/bs.apha.2026.05.005_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40425-017-0227-4","article-title":"Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy","volume":"5","author":"Urak","year":"2017","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"8","key":"10.1016\/bs.apha.2026.05.005_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081317","article-title":"Formulation considerations for autologous T cell drug products","volume":"13","author":"van der Walle","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.05.005_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104216","article-title":"Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint","volume":"83","author":"Verma","year":"2022","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/bs.apha.2026.05.005_bib111","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1182\/bloodadvances.2023011727","article-title":"Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)","volume":"8","author":"Vic","year":"2024","journal-title":"Blood Advances"},{"issue":"5271","key":"10.1016\/bs.apha.2026.05.005_bib112","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.273.5271.104","article-title":"T cell activation determined by T cell receptor number and tunable thresholds","volume":"273","author":"Viola","year":"1996","journal-title":"Science (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib113","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","article-title":"mTOR, metabolism, and the regulation of T-cell differentiation and function","volume":"249","author":"Waickman","year":"2012","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.apha.2026.05.005_bib114","article-title":"Optimizing rAAV6 transduction of primary T cells for the generation of anti-CD19 AAV-CAR-T cells","volume":"150","author":"Wang","year":"2022","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1186\/s12967-022-03833-6","article-title":"A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte count","volume":"20","author":"Wang","year":"2022","journal-title":"Journal of Translational Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2026.05.005_bib116","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/bs.apha.2026.05.005_bib117","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"5626","key":"10.1016\/bs.apha.2026.05.005_bib118","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.1083413","article-title":"Transcription start regions in the human genome are favored targets for MLV integration","volume":"300","author":"Wu","year":"2003","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.apha.2026.05.005_bib119","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cryobiol.2018.06.007","article-title":"Effects of cryopreservation on chimeric antigen receptor T cell functions","volume":"83","author":"Xu","year":"2018","journal-title":"Cryobiology"},{"issue":"8","key":"10.1016\/bs.apha.2026.05.005_bib120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11626-018-0273-3","article-title":"Influence of various medium environment to in vitro human T cell culture","volume":"54","author":"Xu","year":"2018","journal-title":"Vitro Cellular & Developmental Biology. Animal"},{"issue":"7","key":"10.1016\/bs.apha.2026.05.005_bib121","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1172\/JCI85834","article-title":"Glycolysis determines dichotomous regulation of T cell subsets in hypoxia","volume":"126","author":"Xu","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"issue":"24","key":"10.1016\/bs.apha.2026.05.005_bib122","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","article-title":"Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15","volume":"123","author":"Xu","year":"2014","journal-title":"Blood"},{"issue":"709","key":"10.1016\/bs.apha.2026.05.005_bib123","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1951","article-title":"NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates","volume":"15","author":"Yang","year":"2023","journal-title":"Science Translational Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2026.05.005_bib124","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41408-022-00694-6","article-title":"Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study","volume":"12","author":"Yang","year":"2022","journal-title":"Blood Cancer Journal"},{"issue":"24","key":"10.1016\/bs.apha.2026.05.005_bib125","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1182\/bloodadvances.2025017873","article-title":"Predictive markers for the efficacy of CAR T-cell therapy: The interplay between CAR T-cell fitness and systemic immunity","volume":"9","author":"Yoo","year":"2025","journal-title":"Blood Advances"},{"key":"10.1016\/bs.apha.2026.05.005_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120797","article-title":"Biphasic response of T cell activation to substrate stiffness","volume":"273","author":"Yuan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/bs.apha.2026.05.005_bib127","article-title":"Programmable microparticles rewire CAR signaling to enable super-physiological expansion of human T cells in vitro","author":"Zeng","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/bs.apha.2026.05.005_bib128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2026.05.005_bib129","first-page":"45","article-title":"Cholesterol esterification enzyme inhibition enhances antitumor effects of human chimeric antigen receptors modified T cells","volume":"41","author":"Zhao","year":"2018","journal-title":"Journal of Immunotherapy (Hagerstown, Md.: 1997)"},{"issue":"10","key":"10.1016\/bs.apha.2026.05.005_bib130","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s13238-019-0643-y","article-title":"Chimeric antigen receptor T (CAR-T) cells expanded with IL-7\/IL-15 mediate superior antitumor effects","volume":"10","author":"Zhou","year":"2019","journal-title":"Protein Cell"},{"issue":"12","key":"10.1016\/bs.apha.2026.05.005_bib131","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41565-024-01781-4","article-title":"Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies","volume":"19","author":"Zhu","year":"2024","journal-title":"Nature Nanotechnology"}],"container-title":["Advances in Pharmacology","Pharmacology of T-Cell Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:22:25Z","timestamp":1786022545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358926000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443470387"],"references-count":131,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2026.05.005","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}